These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9249003)

  • 1. Cleavage requirements for activation of factor V by factor Xa.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Eur J Biochem; 1997 Jul; 247(1):12-20. PubMed ID: 9249003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage requirements of factor V in tissue-factor induced thrombin generation.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Thromb Haemost; 1998 Jul; 80(1):92-8. PubMed ID: 9684792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin-catalyzed activation of recombinant human factor V.
    Keller FG; Ortel TL; Quinn-Allen MA; Kane WH
    Biochemistry; 1995 Mar; 34(12):4118-24. PubMed ID: 7696276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V.
    Samis JA; Garrett M; Manuel RP; Nesheim ME; Giles AR
    Blood; 1997 Aug; 90(3):1065-74. PubMed ID: 9242537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for expression of factor Va activity.
    Kalafatis M; Beck DO; Mann KG
    J Biol Chem; 2003 Aug; 278(35):33550-61. PubMed ID: 12788947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
    Kalafatis M; Haley PE; Lu D; Bertina RM; Long GL; Mann KG
    Blood; 1996 Jun; 87(11):4695-707. PubMed ID: 8639839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of amino acid region 659-663 of Factor Va heavy chain to the activity of factor Xa within prothrombinase .
    Hirbawi J; Vaughn JL; Bukys MA; Vos HL; Kalafatis M
    Biochemistry; 2010 Oct; 49(39):8520-34. PubMed ID: 20722419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human factor V by factor Xa and thrombin.
    Monkovic DD; Tracy PB
    Biochemistry; 1990 Feb; 29(5):1118-28. PubMed ID: 2322551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms that regulate the anticoagulant function of coagulation factor V.
    Thorelli E
    Scand J Clin Lab Invest Suppl; 1999; 229():19-26. PubMed ID: 10097286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activation.
    Suzuki H; Shima M; Nogami K; Sakurai Y; Nishiya K; Saenko EL; Tanaka I; Yoshioka A
    J Thromb Haemost; 2006 Jun; 4(6):1354-60. PubMed ID: 16706982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
    Marquette KA; Pittman DD; Kaufman RJ
    Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
    Safa O; Morrissey JH; Esmon CT; Esmon NL
    Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The factor V activation paradox.
    Orfeo T; Brufatto N; Nesheim ME; Xu H; Butenas S; Mann KG
    J Biol Chem; 2004 May; 279(19):19580-91. PubMed ID: 14982929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolysis of factor Va by factor Xa and activated protein C.
    Odegaard B; Mann K
    J Biol Chem; 1987 Aug; 262(23):11233-8. PubMed ID: 3611108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana.
    Gerads I; Tans G; Yukelson LYa ; Zwaal RF; Rosing J
    Toxicon; 1992 Sep; 30(9):1065-79. PubMed ID: 1440644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
    Thorelli E; Kaufman RJ; Dahlbäck B
    J Biol Chem; 1998 Jun; 273(26):16140-5. PubMed ID: 9632668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation factor V: a plethora of anticoagulant molecules.
    Kalafatis M
    Curr Opin Hematol; 2005 Mar; 12(2):141-8. PubMed ID: 15725905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of thrombin exosites I and II in the activation of human coagulation factor V.
    Segers K; Dahlbäck B; Bock PE; Tans G; Rosing J; Nicolaes GA
    J Biol Chem; 2007 Nov; 282(47):33915-24. PubMed ID: 17878169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.